Transforming the Treatment of NSCLC Options
Loading Map....
A Case-Based Program: Transforming the Treatment of NSCLC Options for First-Line Treatment of Metastatic EGFR Mutation-Positive Disease and Immunotherapy for Unresectable Stage III Disease
SPEAKER
Viola Zhu, MD
Assistant Clinical Professor of Medicine
University of California, Irvine School of Medicine